Global wearable injectors market was valued at $5,022.2 million in 2020, and is projected to reach $19,518.9 million by 2030, registering a CAGR of 15.3% from 2021 to 2030.The wearable injectors are drug delivery devices that adhere to the body and automatically deliver preset doses to patients at optimal time. Unlike insulin pumps, wearable injectors are single-use systems that are comfortably worn on the body while the drug is subcutaneously administered over a pre-programmed period spanning seconds or hours. Upon full injection of the dose, they are removed from body and conveniently disposed. The development of such devices has been promoted by the concept of patient centricity and an increased focus on human factors in drug delivery design.
Increase in prevalence of chronic diseases such as diabetes, cardiovascular diseases & cancer, increase in use of biologics such as monoclonal antibodies for treatment of diseases, and increase in R&D activities in wearable injector devices such as Bluetooth connectivity with smartphone and digital display are the major factors that drive growth of the market. In addition, increase in number of geriatric patients and rise in demand for home-based treatment further boost the growth of market. Moreover, presence of a well-established healthcare infrastructure and increase in incidence of lifestyle associated diseases are the other factors that fuel the growth of market. However, poor demand in underdeveloped countries and high cost associated with wearable injectors is expected to restrain growth of the wearable injectors market. Conversely, growth opportunities in emerging markets are expected to offer lucrative opportunities during the forecast period.
The World Health Organization (WHO) on January 30, 2020 declared COVID-19 outbreak a public health emergency of international concern. COVID-19 has affected around 210 countries across the globe. The COVID-19 pandemic is an unprecedented global public health challenge and is anticipated to have a positive impact on the wearable injectors market. The COVID-19 pandemic influences entire health care sector to shift toward home-based treatment to avoid further spread of the COVID-19 infection. In addition, recognition of the urgent requirements of global market has encouraged the development of wearable injector device. Thus, COVID-19 infection propels growth and rises opportunities for key players of wearable injectors during the forecast period.
Wearable Injectors Market Segmentation
The wearable injector market is segmented on the basis of type, usage, technology, mechanism of injection, therapeutic area, end user, and region. By type, the market is divided into on body (adhesive patch), off body (belt held), and hand held. By usage, it is classified into disposable and semi-reusable. By technology, it is classified into electronic injectors, mechanical injectors, and others. By mechanism of injection, it is categorized as motor driven, spring driven, expanding battery, rotary pump, collapsible reservoir, and pressurized gas. By therapeutic area, it is divided into diabetes, oncology, cardiovascular disease, infectious disease, and auto immune disorder. By end user, it is divided into clinics, hospitals, ambulatory surgery centers, home care settings, and others. By region, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Segment review
On the basis of type, the market is divided into on-body, and off-body. The on-body injectors segment dominated the market in 2020, and this trend is expected to continue during the forecast period, owing to simple application procedure and do not require additional equipment.
By usage, it is classified into disposable and semi-reusable. The semi-reusable segment dominated the market in 2020, owing to its reusability and production of low medical wastes.
On the basis of technology, it is classified into electronic injectors, mechanical injectors, and others. The mechanical injectors segment dominated the market in 2020, and this trend is expected to continue during the forecast period, owing to its cost effectiveness and smaller device size.
By Type
On-body segment held a dominant position in 2020 and would continue to maintain the lead over the forecast period.
On the basis of mechanism of injection, it is categorized into motor driven, spring driven, expanding battery, rotary pump, collapsible reservoir, and pressurized gas. The spring driven segment dominated the market in 2020, and this trend is expected to continue during the forecast period, owing to its more reliability and easy to use device.
On the basis of therapeutic area, it is divided into diabetes, oncology, cardiovascular disease, infectious disease, and auto immune disorder. The diabetes segment dominated the market in 2020, owing to high prevalence of diabetes worldwide.
On the basis of end user, it is divided into clinics, hospital, ambulatory surgery centers, home care setting, and others. The home care settings segment dominated the market in 2020, and this trend is expected to continue during the forecast period, owing to convenience of use for geriatric population.
By Usage
Semi-reusable held a dominant position in 2020 and would continue to maintain the lead over the forecast period.
Snapshot of Asia-Pacific wearable injectors market
Asia-Pacific presents lucrative opportunities for key players operating in the wearable injectors market, owing to high in prevalence of diabetes, cancer, and cardiovascular diseases, increase in number of hospitals and diagnostic centers, and rise approach for home-based treatments. In addition, approval for the use of various biologics in the treatment of diseases and demand for patient centric therapy contribute toward the growth of the market. Moreover, surge in focus of leading manufacturers on expanding their geographical presence in emerging Asia-Pacific countries to capture high market share is expected to drive the growth of the wearable injectors market in the region.
The key players profiled in this report include Enable Injections, United Therapeutics (Steadymed Therapeutics, Inc.), Insulet Corporation, Medtronic PLC, Sensile Medical Ag, West Pharmaceutical Services, Inc., Becton Dickinson and Company, Buhler Motor Gmbh, Ypsomed, and Eoflow.
By Region
Asia-Pacific would exhibit the highest CAGR of 17.2% during 2021-2030.
Key Benefits For Stakeholders
- The report provides an in-depth analysis of the global wearable injector market size along with the current trends and future estimations to elucidate the imminent investment pockets.
- It offers market analysis from 2021 to 2030, which is expected to enable stakeholders to capitalize on the prevailing opportunities in the market.
- A comprehensive analysis on region assists to understand the regional market and facilitate the strategic business planning and determine prevailing opportunities.
- The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the global wearable injector market growth.
Wearable Injectors Market Report Highlights
| Aspects | Details |
 By Type |
|
 By Usage |
|
 By Technology |
|
 By Mechanism of Injection |
|
 By Therapeutic Area |
|
 By End User |
|
 By Region |
|
Analyst Review
The wearable injectors adhere to the body to administer larger volumes of drug subcutaneously. Wearable injectors releases drug throughout the set period and is used in treatment of chronic diseases.
Factors such as increase in prevalence of chronic diseases, advantages over IV infusion, suitability for large volume of drug, and advancements in wearable injectors are expected to drive growth of the wearable injector market. Moreover, approach for home-based therapy, owing to impact of the COVID-19 further boost growth of the market. However, some therapies such as cancer therapy require medical practitioner monitoring and less acceptability by patients, which hampers the market growth.
The total market value of wearable injectors market is $5,022.2 million in 2020.
The forecast period in the report is from 2021 to 2030
The market value of wearable injectors market in 2021 was $ 5,425.50 million
The base year for the report is 2020.
Yes, wearable injectors companies are profiled in the report
The top companies that hold the market share in wearable injectors market are Enable Injections, United Therapeutics (Steadymed Therapeutics, Inc.), Insulet Corporation, Medtronic PLC, Sensile Medical Ag, West Pharmaceutical Services, Inc., Becton Dickinson and Company, Buhler Motor Gmbh, Ypsomed, and Eoflow.
Asia-Pacific is expected to register the highest CAGR of 17.2% from 2021 to 2030, owing to increase in prevalence of chronic diseases, technical advancements in wearable injectors, and positive impact of COVID-19 on market.
The North America market holds maximum market share of the wearable injectors market.
Loading Table Of Content...
